-
Chapter
Burkitt’s lymphoma: Multiparametric analysis of 55 cell lines with special reference to morphometry
The term ‘Burkitt’s lymphoma’ (BL) connotes a specific morphologic appearance which has been well described [1]. However, the boundaries of this entity from other related B-cell lymphomas, especially the small...
-
Chapter and Conference Paper
Conclusions
The evaluation of the management of NHL in Europe shows that many European groups are today in the favourable position of carrying out clinical research competitive with that of the North-American Study Groups...
-
Chapter and Conference Paper
Stimulation of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor in Lymphoproliferative Diseases
Hematopoietic progenitor cells can be collected from the peripheral blood, cryopreserved, and reinfused after chemotherapy ablation in cancer patients [1]. The advantage of autografting with circulating progen...
-
Chapter
The management of chronic lymphocytic leukemia — a case history
Chronic lymphocytic leukemia (CLL) is a common lymphoproliferative disease. In Western countries, CLL is the leukemia with the highest incidence among persons aged 50 to 55 years and older. Hallmarks of the di...
-
Chapter and Conference Paper
Follicular Lymphomas: Morphology, Prognostic Factors and Treatment
Meaningful discussion of therapy of a disease requires a precise definition of the pathologic entity needing therapy. This requirement is only partially fulfilled for the non-Hodgkin’s lymphomas (NHL). Classif...
-
Chapter and Conference Paper
Alpha-Interferon Role in the Management of Follicular Lymphoma Patients. The GELA Experience
Follicular lymphomas (FL) represent between 20 and 25% of all lymphomas and are slightly more frequent in America than in Europe and less frequent in Asia [1]. They are composed of follicle center cells, a mix...
-
Chapter
Risk-related treatment strategies for diffuse large B cell lymphoma
Patients with large cell lymphoma have differing prognoses. Even within a single histologic subtype, outcome is influenced by a number of factors (not all of which are recognized), and the optimal treatment di...
-
Chapter
Optimal treatment strategies for peripheral T cell lymphoma (unspecified category)
This review combines peripheral “T cell lymphoma, unspecified”, whatever the cell morphology and the specific variants described in the REAL classification [29.1]. If one is going to identify clinical differen...
-
Chapter
Clinical aspects and treatment options of B cell CLL/SLL and immunocytoma
One of the merits of the REAL classification is that it emphasizes different entities and particularly small lymphocytic and lymphoplasmacytic lymphomas. As noted in a preceding chapter, small lymphocytic lymp...